These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3864479)

  • 1. Scoring smack: the illicit heroin market in London, 1980-1983.
    Lewis R; Hartnoll R; Bryer S; Daviaud E; Mitcheson M
    Br J Addict; 1985 Sep; 80(3):281-90. PubMed ID: 3864479
    [No Abstract]   [Full Text] [Related]  

  • 2. Business as usual: heroin distribution in the United States.
    McBride RB
    Int J Health Serv; 1984; 14(4):529-46. PubMed ID: 6500783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The illicit drug market].
    Iannello GD; Delás J; Aguas M; Bacovich I; Serra L; Díaz O
    Gac Sanit; 2012; 26(3):288. PubMed ID: 22361638
    [No Abstract]   [Full Text] [Related]  

  • 4. Doctors not well served by their illicit drug policy.
    Weatherburn D
    Intern Med J; 2005 May; 35(5):312-3; author reply 313-4. PubMed ID: 15845123
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification and quantification of change in Australian illicit drug markets.
    Gilmour S; Koch I; Degenhardt L; Day C
    BMC Public Health; 2006 Aug; 6():200. PubMed ID: 16884546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The illicit non-pharmaceutical heroin market and drug scene in Kensington Market.
    Burr A
    Br J Addict; 1984 Sep; 79(3):337-43. PubMed ID: 6595030
    [No Abstract]   [Full Text] [Related]  

  • 7. Trends in heroin access among adolescents in the United States, 2002-2014.
    Vaughn MG; Salas-Wright CP; Oh S
    Prev Med; 2017 Jun; 99():67-68. PubMed ID: 28189804
    [No Abstract]   [Full Text] [Related]  

  • 8. Learning from uncommon events: comment on Degenhardt et al. 2005.
    Jaffe JH
    Addiction; 2005 Jul; 100(7):921-2; discussion 930-2. PubMed ID: 15955000
    [No Abstract]   [Full Text] [Related]  

  • 9. Narcotics at street level in Denmark. A prospective investigation from 1995 to 2000.
    Simonsen KW; Kaa E; Nielsen E; Rollmann D
    Forensic Sci Int; 2003 Jan; 131(2-3):162-70. PubMed ID: 12590056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heroin in brown, black and white: structural factors and medical consequences in the US heroin market.
    Ciccarone D
    Int J Drug Policy; 2009 May; 20(3):277-82. PubMed ID: 18945606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Today's fentanyl crisis: Prohibition's Iron Law, revisited.
    Beletsky L; Davis CS
    Int J Drug Policy; 2017 Aug; 46():156-159. PubMed ID: 28735773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Availability as a law of addiction.
    Mann RE
    Addiction; 2005 Jul; 100(7):924-5; discussion 930-2. PubMed ID: 15955003
    [No Abstract]   [Full Text] [Related]  

  • 13. The cocaine and heroin markets in the era of globalisation and drug reduction policies.
    Costa Storti C; De Grauwe P
    Int J Drug Policy; 2009 Nov; 20(6):488-96. PubMed ID: 19447024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Globalization and the price decline of illicit drugs.
    Costa Storti C; De Grauwe P
    Int J Drug Policy; 2009 Jan; 20(1):48-61. PubMed ID: 18272358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Documenting the heroin shortage in New South Wales.
    Day C; Degenhardt L; Hall W
    Drug Alcohol Rev; 2006 Jul; 25(4):297-305. PubMed ID: 16854654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "lessons" of the Australian "heroin shortage".
    Degenhardt L; Day C; Gilmour S; Hall W
    Subst Abuse Treat Prev Policy; 2006 May; 1():11. PubMed ID: 16722543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of illicit drug market changes on health agency operations in Sydney, Australia.
    Gibson A; Day C; Degenhardt L
    J Subst Abuse Treat; 2005 Jan; 28(1):35-40. PubMed ID: 15723730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supply control policy, harm reduction and context dependence.
    Weatherburn D
    Addiction; 2005 Jul; 100(7):927-8; discussion 930-2. PubMed ID: 15955006
    [No Abstract]   [Full Text] [Related]  

  • 19. Silicon to syringe: Cryptomarkets and disruptive innovation in opioid supply chains.
    Gilbert M; Dasgupta N
    Int J Drug Policy; 2017 Aug; 46():160-167. PubMed ID: 28735772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-threshold methadone treatment, heroin price, police activity and incidence of heroin use: the Zurich experience.
    Nordt C; Stohler R
    Int J Drug Policy; 2009 Nov; 20(6):497-501. PubMed ID: 19349154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.